Article Description
Self-acceptance could be the key to a happier life, yet it's the happy habit many people practice the least Happiness is more than just a feeling; it is something we can all practice on a daily basis. But people are better at some 'happy habits' than others. In fact, the one habit that corresponds most closely with us being satisfied with our lives overall -- self-acceptance -- is often the one we practice least.
Lack of sleep tied to more health risks for obese adolescents For overweight and obese adolescents, a lack of sleep may be linked to to a higher risk of developing diabetes, heart disease and stroke.
California's quiet reproductive rights revolution The state is bucking a nationwide trend as a wave of new restrictions is forcing abortion providers across the country to shut their doors.
Inherited Alzheimer's damage greater decades before symptoms appear The progression of Alzheimer's may slow once symptoms appear and do significant damage, according to a study investigating an inherited form of the disease. Through an international study, researchers have found rapid neuronal damage begins 10 to 20 years before symptoms appear. The next part of the study involves a clinical trial using a range of imaging techniques, and analysis of blood and cerebrospinal fluid, as participants trial new drugs to test their safety, side effects and changes within the brain.
Free Play: Simple Items More Fun For Children Study finds children play more intensely and vigorously with crates, pipes and buckets than with monkey bars and slides.→ Dr Jeremy Dean is a psychologist and author of PsyBlog. His latest book is "Making Habits, Breaking Habits: How to Make Changes That Stick"
Talking-therapy treatments to manage osteoarthritis pain Abnormalities in the way the brain experiences pain may be to blame for the chronic pain suffered by osteoarthritis patients, scientists have shown for the first time. As a results, the researchers suggest that new therapies should target brain mechanisms to enable the brain to cope more effectively with chronic pain, including mindfulness-based talking therapies.
Genetic Trigger Discoverd For Most Common Form of Mental Disability and Autism New drug given during pregnancy may help treat fragile X syndrome, a leading genetic cause of autism.→ Dr Jeremy Dean is a psychologist and author of PsyBlog. His latest book is "Making Habits, Breaking Habits: How to Make Changes That Stick"
At last, a promising alternative to antipsychotics for schizophrenia | Daniel and Jason Freeman For many, the side-effects of antipsychotics are worse than the symptoms they're meant to treat. No wonder some people with schizophrenia refuse to take themImagine that, after feeling unwell for a while, you visit your GP. "Ah," says the doctor decisively, "what you need is medication X. It's often pretty effective, though there can be side-effects. You may gain weight. Or feel drowsy. And you may develop tremors reminiscent of Parkinson's disease." Warily, you glance at the prescription on the doctor's desk, but she hasn't finished. "Some patients find that sex becomes a problem. Diabetes and heart problems are a risk. And in the long term the drug may actually shrink your brain ... "This scenario may sound far-fetched, but it is precisely what faces people diagnosed with schizophrenia. Since the 1950s, the illness has generally been treated using antipsychotic drugs – which, as with so many medications, were discovered by chance. A French surgeon investigating treatments for surgical shock found that one of the drugs he tried – the antihistamine chlorpromazine – produced powerful psychological effects. This prompted the psychiatrist Pierre Denker to give the drug to some of his most troubled patients. Their symptoms improved dramatically, and a major breakthrough in the treatment of psychosis seemed to have arrived.Many other antipsychotic drugs have followed in chlorpromazine's wake and today these medications comprise 10% of total NHS psychiatric prescriptions. They are costly items: the NHS spends more on these medications than it does for any other psychiatric drug, including antidepressants. Globally, around $14.5bn is estimated to be spent on neuroleptics each year.Since the 1950s the strategy of all too many NHS mental health teams has been a simple one. Assuming that psychosis is primarily a biological brain problem, clinicians prescribe a neuroleptic medication and everyone does their level best to get the patient to take it, often for long periods. There can be little doubt that these drugs make a positive difference, reducing delusions and hallucinations and making relapse less likely – provided, that is, the patient takes their medication.Unfortunately, dropout rates are high. This is partly because individuals sometimes don't accept that they are ill. But a major reason is the side-effects. These vary from drug to drug, but they're common and for many people are worse than the symptoms they are designed to treat.In addition, antipsychotics don't work for everyone. It is estimated that six months after first being prescribed them, as many as 50% of patients are either taking the drugs haphazardly or not at all.The conventional treatment for this most severe of psychiatric illnesses, then, is expensive, frequently unpleasant, and not always effective even for those who carry on taking the drugs. But it is what we have relied upon – which helps to explain why the results of a clinical trial, recently published in The Lancet, have generated so much interest and debate.A team led by Professor Anthony Morrison at the University of Manchester randomly assigned a group of patients, all of whom had opted not to take antipsychotics, to treatment as usual (involving a range of non-pharmaceutical care) or to treatment as usual plus a course of cognitive therapy (CT). Drop-out rates for the cognitive therapy were low, while its efficacy in reducing the symptoms of psychosis was comparable to what medication can achieve.So what exactly is CT for schizophrenia? At its core is the idea that the patient should be encouraged to talk about their experiences – just as they would for every other psychological condition. Psychosis isn't viewed as a biological illness that one either has or does not have. Instead, just like every other mental disorder, psychotic experiences are seen as the severest instances of thoughts and feelings – notably delusions and hallucinations – that many of us experience from time to time.Working together, the patient and therapist develop a model of what's causing the experiences, and why they're recurring. These factors will vary from person to person, so what is produced is a bespoke account of the individual's experience, which is then used to guide treatment. For example, a person so worried by paranoid fears that they won't set foot outside might be helped to trace the roots of their anxiety to past experiences; to gradually test out their fearful thoughts; and to learn to manage their anxiety while getting on with the activities they enjoy. An individual troubled by hearing voices will be helped to understand what's triggering these voices, and to develop a more confident, empowering relationship with them.These are early days. Nevertheless, most of the meta-analyses of CT's efficacy for psychosis, when added to standard treatment, have indicated definite (albeit modest) benefits for patients, with the latest showing that CT is better than other psychological treatments for reducing delusions and hallucinations. The latest guidelines from the UK's National Institute for Health and Care Excellence (Nice) recommend it for those at risk of psychosis and, when combined with medication, for people with an ongoing problem.But not everyone is convinced, and although the research published in The Lancet is encouraging, it was small scale. CT for psychosis is still evolving, and we think that evolution should prioritise three key areas.First, we must focus on understanding and treating individual psychotic experiences. As we've reported in a previous post, there is increasing reason to doubt the usefulness of the diagnosis "schizophrenia". The term has been used as a catch-all for an assortment of unusual thoughts and feelings that often have no intrinsic connections, and aren't qualitatively different from those experienced by the general population. Each psychotic experience may therefore require a tailored treatment.Second, we must build on the recent transformation in understanding the causes of psychotic experiences, taking one factor at a time (insomnia, say, or worry), developing an intervention to change it, and then observing the effects of that intervention on an individual's difficulties.And finally, we must listen to what patients want from their treatment – for example, by focusing on improving levels of wellbeing, which tend to be very low among people with schizophrenia.What about costs compared with drug treatment? A course of CBT is typically just over £1,000, but if it leads to a reduction in the amount of time patients spend in hospital and their use of other services, or a return to work, then it easily pays for itself.The Nice guidance on psychosis and schizophrenia, updated this year, is unequivocal:"The systematic review of economic evidence showed that provision of CBT to people with schizophrenia in the UK improved clinical outcomes at no additional cost. This finding was supported by economic modelling undertaken for this guideline, whichsuggested that provision of CBT might result in net cost savings to the NHS, associated with a reduction in future hospitalisation rates."If the real promise of cognitive therapy can be fulfilled, we may at last have a genuinely effective, relatively cheap, and side-effect-free alternative to antipsychotics for those patients who don't wish to take them. Watch this space.Daniel and Jason Freeman are the authors of Paranoia: the 21st Century Fear. Daniel is a professor of clinical psychology and a Medical Research Council Senior Clinical Fellow at the University of Oxford, and a Fellow of University College, Oxford. Twitter: @ProfDFreeman. Jason is a psychology writer. Twitter: @JasonFreeman100PsychologyDrugsMedical researchSchizophreniaMental healthHealthDaniel FreemanJason Freemantheguardian.com © 2014 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds
Genetic Trigger Discovered For Most Common Form of Mental Disability and Autism New drug given during pregnancy may help treat fragile X syndrome, a leading genetic cause of autism.→ Dr Jeremy Dean is a psychologist and author of PsyBlog. His latest book is "Making Habits, Breaking Habits: How to Make Changes That Stick" Related articles:The Genetic Predisposition to Focus on the Negative Autism: Vital Link Found Between Vitamin D and Serotonin Production Probiotic Therapy Shows Promise for Treating Autism Autism: 10 Facts You Should Know How New Ideas Change Your Brain Cells
APA Informs Federal Officials of Policy Changes Related to Detainee Welfare and Interrogation in National Security Settings Calls on federal agencies to avoid placing health providers in roles and situations that conflict with professional ethics
Drug protects mice against malaria brain damage, raises levels of BDNF in humans Cerebral malaria is a serious complication of infection with the malaria parasite, affecting approximately one in a thousand children in areas where malaria is common. Many of the patients die, and among those who survive, about a third have lasting cognitive and neurological disabilities, including epilepsy and learning disorders. A new study shows that a known drug can prevent brain damage in a cerebral malaria mouse model and eliminate subsequent neurological deficits.
64 Ways To Cope With Cravings Do you struggle with cravings? Do you feel as though they are limiting your ability to live life to your utmost potential? If so contact Watersedgecounselling on 0434 337 245 for a FREE 10-minute phone consultation on how we can best help you or press book now to book in our online diary.
What Happens to Sexual Desire in an Egalitarian Marriage? Emphasizing an egalitarian bond, reducing traditional gender roles, and focusing on emotional problem-solving to foster a shared intimate relationship is a healthy marital trend. For most couples, this results in greater marital satisfaction and security. The question is whether an intimate, egalitarian marriage promotes or subverts couple sexuality?read more
Marijuana's anxiety relief effects: Receptors found in emotional hub of brain Cannabinoid receptors, through which marijuana exerts its effects, have been found in a key emotional hub in the brain involved in regulating anxiety and the flight-or-fight response. This is the first time cannabinoid receptors have been identified in the central nucleus of the amygdala in a mouse model.
'Seeing' bodies with sound (no sight required) People born unable to see are readily capable of learning to perceive the shape of the human body through soundscapes that translate images into sound, according to researchers. With a little training, soundscapes representing the outlines and silhouettes of bodies cause the brain's visual cortex -- and specifically an area dedicated in normally sighted people to processing body shapes -- to light up with activity.
Computers used to 'see' neurons to better understand brain function A study reveals new information about the motor circuits of the brain that may one day help those developing therapies to treat conditions such as stroke, schizophrenia, spinal cord injury or Alzheimer's disease. In this study, which processed images and reconstructed neuronal motor circuitry in the brain, the researchers collected and analyzed data on minute structures over various developmental stages, linking neuroscience and computer science.
For women to thrive, men should lean out Fewer women than men feel confident they will make it to the top of their companies.
Helping teen girls get on the 'write' path Writing gives at-risk girls the confidence to speak up and reach out for help in school, in their relationships and at home.
Learning how to listen with neurofeedback When listening to music or learning a new language, auditory perceptual learning occurs: a process in which your recognition of specific sounds improves, making you more efficient in processing and interpreting them. A neuroscientist now shows that auditory perceptual learning can be facilitated using neurofeedback, helping to focus on the sound differences that really matter.
Meditation Can Make You More Creative Particular types of meditation can generate insight and new ideas, according to recent studies.→ Dr Jeremy Dean is a psychologist and author of PsyBlog. His latest book is "Making Habits, Breaking Habits: How to Make Changes That Stick"